4//SEC Filing
Berger Dietmar 4
Accession 0001127602-25-000548
CIK 0000882095other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 6:38 PM ET
Size
5.4 KB
Accession
0001127602-25-000548
Insider Transaction Report
Form 4
Berger Dietmar
Chief Medical Officer
Transactions
- Award
Restricted Stock Unit
2025-01-02+48,975→ 48,975 total→ Common Stock (48,975 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a three year vesting schedule. 33.33% will vest on the anniversary of the date of grant until fully vested.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001739515
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 6:38 PM ET
- Size
- 5.4 KB